高级别胶质瘤中的肿瘤相关癫痫:一项大型系列生存分析
该单中心回顾性研究纳入950例组织学确诊的高级别胶质瘤患者,按诊断前或诊断后出现癫痫发作分组,采用多因素Cox比例风险模型评估生存预后。结果显示诊断前(HR=0.81,95%CI=0.68-0.96,P=0.017)或诊断后(HR=0.74,95%CI=0.60-0.91,P=0.005)出现癫痫活动与总生存改善相关;晚发性癫痫与较早发性癫痫患者相比,达到部分或完全癫痫控制的几率更低。
要点
- 诊断前出现癫痫发作与总生存改善相关(HR=0.81,95%CI=0.68-0.96,P=0.017)。
- 诊断后出现癫痫发作与总生存改善相关(HR=0.74,95%CI=0.60-0.91,P=0.005)。
- 晚发性癫痫与较早发性癫痫相比,达到部分或完全癫痫控制的几率更低。
核心结论
- 诊断时及治疗过程中出现的临床癫痫发作均与高级别胶质瘤患者总生存改善相关。
- 该关联可能在IDH1野生型和IDH1突变患者中均持续存在,但需进一步研究。
研究设计与样本
- 单中心回顾性研究,纳入950例组织学确诊的高级别胶质瘤患者。
- 癫痫发作按临床病史分为早发性(高级别胶质瘤表现后30天内发生)或晚发性(开始高级别胶质瘤治疗后首次发作)。
- 主要结局为总生存和无进展生存的风险比,采用多因素Cox比例风险模型评估。
- IDH1突变状态通过免疫组化评估,仅自2015年起持续可获取;在已知IDH1状态的亚组中进行了亚组分析。
主要发现
- 高级别胶质瘤诊断前出现癫痫活动与总生存改善相关(HR=0.81,95%CI=0.68-0.96,P=0.017)。
- 高级别胶质瘤诊断后出现癫痫活动与总生存改善相关(HR=0.74,95%CI=0.60-0.91,P=0.005)。
- 晚发性癫痫与早发性癫痫患者相比,达到部分癫痫控制的几率更低(OR=0.25,95%CI=0.12-0.53,P<0.001)。
- 晚发性癫痫与早发性癫痫患者相比,达到完全癫痫控制的几率更低(OR=0.30,95%CI=0.18-0.50,P<0.001)。
局限性
- IDH1突变状态仅自2015年起持续可获取,亚组分析仅在已知IDH1状态的患者中进行。
- 该关联可能在IDH1野生型和IDH1突变患者中均持续存在,但需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Seizures are a common clinical occurrence in high-grade glioma (HGG). While many studies have explored seizure incidence and prevalence in HGG, limited studies have examined the prognostic effect of seizures occurring in the post-diagnosis setting. This study aims to assess the impact of seizure presentation on HGG survival outcomes. METHODS: Single-center retrospective review identified 950 patients with histologically-confirmed high-grade glioma. Seizure presentation was determined by clinical history and classified as early onset (occurring within 30 days of HGG presentation) or late onset (first seizure occurring after beginning HGG treatment). The primary outcome, hazard ratios for overall survival and progression-free survival, was assessed with multivariable Cox proportional-hazards models. IDH1 mutation status (assessed through immunohistochemistry) was only consistently available beginning in 2015; subgroup analyses were performed in the subset of patients with known IDH1 status. RESULTS: Epileptic activity before (HR = 0.81, 95% CI = 0.68-0.96, P = 0.017) or after (HR = 0.74, 95% CI = 0.60-0.91, P = 0.005) HGG diagnosis associated with improved overall survival. Additionally, late seizure onset significantly associated with lower odds of achieving partial (OR = 0.25, 95% CI = 0.12-0.53, P = < 0.001) or complete (OR = 0.30, 95% CI = 0.18-0.50, P < 0.001) seizure control than patients with early seizure onset. CONCLUSIONS: Clinical seizures both at the time of diagnosis and later during the HGG treatment course are associated with improved overall survival. This association potentially persists for both IDH1-wildtype and IDH1-mutant patients, but further study is required.
引用
- Rilinger RG, Guo L, Sharma A, et al. Tumor-related epilepsy in high-grade glioma: a large series survival analysis. J Neurooncol. 2024. PMID: 39102118. doi:10.1007/s11060-024-04787-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。